Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
NCT01849848
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
DRUG:
SyB L-0501
Sponsor
SymBio Pharmaceuticals